Brokerages Set Cigna Group (NYSE:CI) PT at $330.00

Cigna Group (NYSE:CIGet Free Report) has received an average rating of “Moderate Buy” from the twenty-two brokerages that are covering the company, Marketbeat.com reports. Five equities research analysts have rated the stock with a hold rating, sixteen have assigned a buy rating and one has given a strong buy rating to the company. The average 1-year price objective among brokers that have updated their coverage on the stock in the last year is $330.6316.

CI has been the subject of a number of research reports. Morgan Stanley reiterated an “overweight” rating and issued a $355.00 price objective on shares of Cigna Group in a research report on Friday, October 31st. Wall Street Zen upgraded shares of Cigna Group from a “hold” rating to a “buy” rating in a research report on Saturday, February 7th. JPMorgan Chase & Co. decreased their target price on Cigna Group from $428.00 to $375.00 and set an “overweight” rating on the stock in a report on Tuesday, November 4th. Mizuho set a $325.00 target price on shares of Cigna Group in a research report on Friday, January 9th. Finally, Deutsche Bank Aktiengesellschaft lifted their target price on Cigna Group from $301.00 to $304.00 and gave the company a “buy” rating in a research note on Tuesday, February 10th.

Check Out Our Latest Analysis on CI

Cigna Group Trading Up 0.9%

Shares of CI stock opened at $282.97 on Tuesday. The firm has a market capitalization of $75.59 billion, a P/E ratio of 12.76, a price-to-earnings-growth ratio of 0.97 and a beta of 0.27. Cigna Group has a 1 year low of $239.51 and a 1 year high of $350.00. The firm’s fifty day simple moving average is $279.03 and its 200 day simple moving average is $284.37. The company has a current ratio of 0.74, a quick ratio of 0.76 and a debt-to-equity ratio of 0.74.

Cigna Group (NYSE:CIGet Free Report) last posted its quarterly earnings results on Thursday, February 5th. The health services provider reported $8.08 earnings per share (EPS) for the quarter, topping the consensus estimate of $7.88 by $0.20. Cigna Group had a net margin of 2.17% and a return on equity of 19.46%. The company had revenue of $72.50 billion for the quarter, compared to analyst estimates of $69.53 billion. During the same period last year, the business posted $6.64 EPS. The business’s quarterly revenue was up 10.4% on a year-over-year basis. Cigna Group has set its FY 2026 guidance at 30.250- EPS. As a group, sell-side analysts predict that Cigna Group will post 29.77 EPS for the current year.

Cigna Group Increases Dividend

The firm also recently disclosed a quarterly dividend, which will be paid on Thursday, March 19th. Investors of record on Thursday, March 5th will be issued a $1.56 dividend. This is an increase from Cigna Group’s previous quarterly dividend of $1.51. This represents a $6.24 annualized dividend and a yield of 2.2%. The ex-dividend date is Thursday, March 5th. Cigna Group’s dividend payout ratio (DPR) is currently 28.13%.

Institutional Trading of Cigna Group

Several institutional investors and hedge funds have recently made changes to their positions in CI. Vanguard Group Inc. increased its holdings in Cigna Group by 1.6% in the fourth quarter. Vanguard Group Inc. now owns 26,173,577 shares of the health services provider’s stock valued at $7,203,754,000 after purchasing an additional 414,834 shares during the last quarter. State Street Corp raised its holdings in Cigna Group by 1.8% in the fourth quarter. State Street Corp now owns 12,339,250 shares of the health services provider’s stock worth $3,396,132,000 after purchasing an additional 224,122 shares during the period. Massachusetts Financial Services Co. MA boosted its position in shares of Cigna Group by 8.3% during the fourth quarter. Massachusetts Financial Services Co. MA now owns 11,805,083 shares of the health services provider’s stock worth $3,249,113,000 after purchasing an additional 903,334 shares in the last quarter. Dodge & Cox grew its holdings in shares of Cigna Group by 19.7% in the 4th quarter. Dodge & Cox now owns 11,138,614 shares of the health services provider’s stock valued at $3,065,681,000 after buying an additional 1,833,389 shares during the period. Finally, Sanders Capital LLC increased its position in shares of Cigna Group by 0.5% in the 3rd quarter. Sanders Capital LLC now owns 7,828,168 shares of the health services provider’s stock valued at $2,256,469,000 after buying an additional 35,150 shares in the last quarter. Institutional investors own 86.99% of the company’s stock.

About Cigna Group

(Get Free Report)

Cigna Group (NYSE: CI) is a global health services company that offers a broad portfolio of healthcare products and insurance solutions for individuals, employers, and governments. Its core businesses include medical and behavioral health plans, dental and vision coverage, pharmacy benefit management, and supplemental health products. Cigna serves a mix of commercial, Medicare, and Medicaid customers and provides workplace benefits such as group health plans and disability and life benefits for employers.

In addition to traditional insurance products, Cigna operates health services and care-delivery platforms designed to manage costs and improve outcomes.

See Also

Analyst Recommendations for Cigna Group (NYSE:CI)

Receive News & Ratings for Cigna Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cigna Group and related companies with MarketBeat.com's FREE daily email newsletter.